Assignee
BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD
CN·30 granted patents·39 pending applications·11 citations·filing 2017–2024
Top patents by PatentIndex Score
69 records- 0188US11352429B2Anti-PD-1 antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Granted Jun 7, 2022·1 cites·26 claims
- 0288US10973212B2Genetically modified non-human animal with human or chimeric SIRPaBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Apr 13, 2021·4 cites·19 claims
- 0383US11439132B2Humanized transgenic animalBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Sep 13, 2022·1 cites·14 claims
- 0482US10945420B2Genetically modified non-human animal with human or chimeric CD3eBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Mar 16, 2021·1 cites·18 claims
- 0582US10912287B2Genetically modified mice expressing humanized PD-1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted Feb 9, 2021·2 cites·13 claims
- 0681US2025129164A1Anti-pd-1 antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2024·Application pending·0 cites
- 0780US10925264B2Genetically modified non-human animal with human or chimeric LAG-3BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Feb 23, 2021·1 cites·12 claims
- 0876US2024284885A1Genetically modified non-human animals with common light chain immunoglobulin locusBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2024·Application pending·0 cites
- 0975US12180281B2Anti-PD-1 antibodies and methods of treating cancerBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Granted Dec 31, 2024·0 cites·30 claims
- 1075US2024373831A1Genetically modified non-human animals with humanized immunoglobulin locusBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2024·Application pending·0 cites
- 1173US11997994B2Genetically modified non-human animals with common light chain immunoglobulin locusBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 1273US11730151B2Genetically modified non-human animals with humanized immunoglobulin locusBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Granted Aug 22, 2023·0 cites·19 claims
- 1372US11723348B2Genetically modified mice expressing humanized CD47BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Aug 15, 2023·0 cites·13 claims
- 1472US11279948B2Genetically modified non-human animal with human or chimeric OX40BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted Mar 22, 2022·1 cites·11 claims
- 1570US11071290B2Genetically modified non-human animal with human or chimeric CTLA-4BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Jul 27, 2021·0 cites·13 claims
- 1669US2024360201A1Modified immunoglobulinsBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2024·Application pending·0 cites
- 1769US2023043907A1Humanized transgenic animalBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 1868US12342800B2Immunodeficient non-human animalBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Jul 1, 2025·0 cites·21 claims
- 1968US2025382373A1Anti-egfr/met antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 2067US11154041B2Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Oct 26, 2021·0 cites·17 claims
- 2166US12016315B2Genetically modified non-human animal with human or chimeric CD3eBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Granted Jun 25, 2024·0 cites·19 claims
- 2266US2026078197A1Genetically modified non-human animals and methods for producing heavy-chain antibodiesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 2365US12004495B2Genetically modified non-human animals with humanized immunoglobulin locusBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2020·Granted Jun 11, 2024·0 cites·22 claims
- 2465US11987615B2Modified immunoglobulinsBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Granted May 21, 2024·0 cites·17 claims
- 2565US10980222B2Genetically modified non-human animal with human or chimeric CD27BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Apr 20, 2021·0 cites·12 claims
- 2664US11464876B2Genetically modified mouse comprising a chimeric TIGITBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Oct 11, 2022·0 cites·5 claims
- 2764US11234420B2Method for constructing PD-1 gene modified humanized animal model and use thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Feb 1, 2022·0 cites·15 claims
- 2864US2022000086A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 2963US11240995B2Genetically modified non-human animal with human or chimeric TIM-3BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Feb 8, 2022·0 cites·20 claims
- 3063US2025185635A1Genetically modified non-human animals with humanized immunoglobulin and mhc lociBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 3162US11096383B2Method of using a genetically modified mouse that expresses a humanized CTLA-4 geneBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted Aug 24, 2021·0 cites·13 claims
- 3262US2025302016A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 3361US11505806B2Genetically modified non-human animal with human or chimeric OX40BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Nov 22, 2022·0 cites·9 claims
- 3461US2025120374A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 3561US2025134079A1Genetically modified non-human animal with human or chimeric genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 3660US11272695B2Genetically modified non-human animal with human or chimeric PD-1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 3760US10945418B2Genetically modified non-human animal with human or chimeric PD-L1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Mar 16, 2021·0 cites·11 claims
- 3860US2025143272A1Genetically modified non-human animal with human or chimeric nkp46BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 3959US2025059297A1Anti-her2/trop2 antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 4059US2024268361A1Genetically modified non-human animal with human or chimeric tfr1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 4158US11497198B2Genetically modified mice expressing humanized CD40BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Granted Nov 15, 2022·0 cites·4 claims
- 4258US2025115668A1Anti-ctla4/ox40 bispecific antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 4358US2025361296A1Anti-siglec15 antibodies and uses thereofBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 4455US11534502B2Genetically modified non-human animal with human or chimeric TIGITBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted Dec 27, 2022·0 cites·6 claims
- 4555US11317611B2Genetically modified non-human animal with human or chimeric PD-L1BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2017·Granted May 3, 2022·0 cites·13 claims
- 4655US2024081301A1Genetically modified non-human animal with human or chimeric fcrnBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 4755US2023172171A1Genetically modified non-human animal with human or chimeric cd94 and/or nkg2aBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 4855US2023227531A1Genetically modified non-human animal expressing a b2m/fcrn fusion proteinBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 4955US2024130340A1Genetically modified non-human animal with human or chimeric cd3 genesBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 5055US2022071185A1Genetically modified non-human animal with human or chimeric cd137BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →